View in EDS

Phase II evaluation of gefitinib in patients with newly diagnosed Grade 4 astrocytoma: Mayo/North Central Cancer Treatment Group Study N0074.

Saved in:
Bibliographic Details
Title: Phase II evaluation of gefitinib in patients with newly diagnosed Grade 4 astrocytoma: Mayo/North Central Cancer Treatment Group Study N0074.
Authors: Uhm JH; Division of Neuro-Oncology, Department of Neurology, Mayo Clinic Rochester, Rochester, MN 55905, USA. uhm.joon@mayo.edu, Ballman KV, Wu W, Giannini C, Krauss JC, Buckner JC, James CD, Scheithauer BW, Behrens RJ, Flynn PJ, Schaefer PL, Dakhill SR, Jaeckle KA
Source: International journal of radiation oncology, biology, physics [Int J Radiat Oncol Biol Phys] 2011 Jun 01; Vol. 80 (2), pp. 347-53. Date of Electronic Publication: 2010 May 25.
Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Elsevier, Inc Country of Publication: United States NLM ID: 7603616 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-355X (Electronic) Linking ISSN: 03603016 NLM ISO Abbreviation: Int J Radiat Oncol Biol Phys Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 20510539
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Phase II evaluation of gefitinib in patients with newly diagnosed Grade 4 astrocytoma: Mayo/North Central Cancer Treatment Group Study N0074.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Uhm+JH%22">Uhm JH</searchLink>; Division of Neuro-Oncology, Department of Neurology, Mayo Clinic Rochester, Rochester, MN 55905, USA. uhm.joon@mayo.edu<br /><searchLink fieldCode="AU" term="%22Ballman+KV%22">Ballman KV</searchLink><br /><searchLink fieldCode="AU" term="%22Wu+W%22">Wu W</searchLink><br /><searchLink fieldCode="AU" term="%22Giannini+C%22">Giannini C</searchLink><br /><searchLink fieldCode="AU" term="%22Krauss+JC%22">Krauss JC</searchLink><br /><searchLink fieldCode="AU" term="%22Buckner+JC%22">Buckner JC</searchLink><br /><searchLink fieldCode="AU" term="%22James+CD%22">James CD</searchLink><br /><searchLink fieldCode="AU" term="%22Scheithauer+BW%22">Scheithauer BW</searchLink><br /><searchLink fieldCode="AU" term="%22Behrens+RJ%22">Behrens RJ</searchLink><br /><searchLink fieldCode="AU" term="%22Flynn+PJ%22">Flynn PJ</searchLink><br /><searchLink fieldCode="AU" term="%22Schaefer+PL%22">Schaefer PL</searchLink><br /><searchLink fieldCode="AU" term="%22Dakhill+SR%22">Dakhill SR</searchLink><br /><searchLink fieldCode="AU" term="%22Jaeckle+KA%22">Jaeckle KA</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%227603616%22">International journal of radiation oncology, biology, physics</searchLink> [Int J Radiat Oncol Biol Phys] 2011 Jun 01; Vol. 80 (2), pp. 347-53. <i>Date of Electronic Publication: </i>2010 May 25.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%2C+Inc%22">Elsevier, Inc </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>7603616 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1879-355X (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2203603016%22">03603016 </searchLink><i>NLM ISO Abbreviation: </i>Int J Radiat Oncol Biol Phys <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=20510539
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.ijrobp.2010.01.070
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 347
    Titles:
      – TitleFull: Phase II evaluation of gefitinib in patients with newly diagnosed Grade 4 astrocytoma: Mayo/North Central Cancer Treatment Group Study N0074.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Uhm JH
      – PersonEntity:
          Name:
            NameFull: Ballman KV
      – PersonEntity:
          Name:
            NameFull: Wu W
      – PersonEntity:
          Name:
            NameFull: Giannini C
      – PersonEntity:
          Name:
            NameFull: Krauss JC
      – PersonEntity:
          Name:
            NameFull: Buckner JC
      – PersonEntity:
          Name:
            NameFull: James CD
      – PersonEntity:
          Name:
            NameFull: Scheithauer BW
      – PersonEntity:
          Name:
            NameFull: Behrens RJ
      – PersonEntity:
          Name:
            NameFull: Flynn PJ
      – PersonEntity:
          Name:
            NameFull: Schaefer PL
      – PersonEntity:
          Name:
            NameFull: Dakhill SR
      – PersonEntity:
          Name:
            NameFull: Jaeckle KA
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 06
              Text: 2011 Jun 01
              Type: published
              Y: 2011
          Identifiers:
            – Type: issn-electronic
              Value: 1879-355X
          Numbering:
            – Type: volume
              Value: 80
            – Type: issue
              Value: 2
          Titles:
            – TitleFull: International journal of radiation oncology, biology, physics
              Type: main
ResultId 1